InsiderTrades

Form 4 for SOLV Solventum

Accepted 2026-05-15 16:11:07 ET · period of report 2026-05-13 · accession 0001768648-26-000005 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-05-15 16:11 2026-05-13 SOLV McMillan Wayde D. CFO M - OptEx $0.00 +9,503 53.0K +22% $0
D 2026-05-15 16:11 2026-05-13 SOLV McMillan Wayde D. CFO F - Tax $74.41 -4,404 48.6K -8% -$327.7K
D 2026-05-15 16:11 2026-05-13 SOLV McMillan Wayde D. CFO M - OptEx $0.00 -9,503 9,504 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-05-13 M A 9,503 $0.00 53,041 D — —
2 Common Common Stock 2026-05-13 F D 4,404 $74.41 48,637 D — —
3 Derivative Restricted Stock Units 2026-05-13 M D 9,503 $0.00 9,504 D — · — to 2034-05-13 9,503 Common Stock (F1) Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. (F2) The RSUs shall fully vest in three tranches, with one-third vesting on each of May 13, 2025; May 13, 2026; and May 13, 2027, subject to continued service through the vesting date.